ASX · SHG.AX
Singular Health Group Ltd
A$0.18+A$0.00 (0.0%)
Singular Health Group Ltd’s quoted price sits in the lower half of its reported 52-week range, 40.0% below the high.
Loading market information…
ASX · M7T.AX · AUD
Stock price, earnings
Quote as of Oct 30, 2026, 01:07 AM UTC. Cached market data; not a live quote.
One-year closing-price history · AUD. Historical prices are not a forecast.
Mach7 Technologies Limited’s quoted price sits in the lower half of its reported 52-week range, 62.77% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Mach7 Technologies Limited’s next earnings report is currently expected on Mar 3, 2027, with estimated earnings per share of -A$0.01. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Mach7 Technologies Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Mach7 Technologies Limited develops and commercializes medical imaging and data management software solutions for healthcare organizations in North America, the Asia Pacific, the Middle East, Europe, and internationally. It offers eUnity enterprise diagnostic viewer, a zero-footprint viewer that allows medical professionals to remotely access patients’ medical images; vendor-neutral archive (VNA), a vendor-agnostic data management solution, which includes administration tools that allow for the storage, access, retrieval, and viewing of images across a healthcare network. The company also provides workflow applications, such as a universal worklist, quality control (QC) tools designed for technologists’ workflows; image sharing and exchange capabilities; teleradiology services; and additional specialized tools to serve departmental patient care needs. Mach7 Technologies Limited was founded in 2007 and is headquartered in South Burlington, Vermont.
Latest available per-share figures in AUD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:57 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q2 2024 | Feb 29, 2024 | -A$0.02+3.65% vs estimate | A$13.33M-55.63% vs estimate |
|---|
| Q4 2023 | Aug 31, 2023 | -A$0.00 | A$13.64M-54.62% vs estimate |
|---|
| Q2 2023 | Feb 28, 2023 | -A$0.00-103.33% vs estimate | A$16.41M+32.16% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
A$0.18+A$0.00 (0.0%)
Singular Health Group Ltd’s quoted price sits in the lower half of its reported 52-week range, 40.0% below the high.
A$0.44+A$0.05 (+12.99%)
Cyclopharm Limited’s quoted price sits in the lower half of its reported 52-week range, 66.28% below the high.
A$0.23-A$0.01 (-2.13%)
Compumedics Limited’s quoted price sits in the lower half of its reported 52-week range, 48.89% below the high.
A$0.09-A$0.00 (-2.25%)
Amplia Therapeutics Limited’s quoted price sits in the lower half of its reported 52-week range, 68.36% below the high.
A$0.10-A$0.01 (-4.76%)
Doctor Care Anywhere Group PLC’s quoted price sits in the lower half of its reported 52-week range, 48.72% below the high.
A$0.04-A$0.00 (-5.13%)
Micro-X Limited’s quoted price sits in the lower half of its reported 52-week range, 67.83% below the high.
A$0.07A$0.00 (0.0%)
Beamtree Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 68.44% below the high.
A$0.08-A$0.00 (-1.27%)
Genetic Signatures Limited’s quoted price sits in the lower half of its reported 52-week range, 77.39% below the high.
